OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.700
-0.060 (-3.41%)
At close: Feb 20, 2026, 4:00 PM EST
1.720
+0.020 (1.18%)
After-hours: Feb 20, 2026, 7:34 PM EST
OKYO Pharma Market Cap
OKYO Pharma has a market cap or net worth of $87.33 million as of February 20, 2026. Its market cap has increased by 127.73% in one year.
Market Cap
87.33M
Enterprise Value
83.29M
1-Year Change
127.73%
Ranking
Category
Stock Price
$1.70
Market Cap Chart
Since the IPO on September 4, 2013, OKYO Pharma's market cap has decreased from $141.20M to $87.33M, a decrease of -38.15%. That is a compound annual growth rate of -3.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 90.41M | 16.13% |
| Dec 31, 2025 | 77.85M | 100.10% |
| Dec 31, 2024 | 38.91M | -33.86% |
| Dec 29, 2023 | 58.83M | 38.58% |
| Dec 20, 2022 | 42.45M | -48.55% |
| Dec 10, 2021 | 82.51M | 4.85% |
| Dec 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Verrica Pharmaceuticals | 100.74M |
| Turn Therapeutics | 100.11M |
| Actuate Therapeutics | 98.55M |
| Anixa Biosciences | 97.47M |
| Dogwood Therapeutics | 96.89M |
| Cognition Therapeutics | 96.22M |
| Pyxis Oncology | 95.26M |
| Precision BioSciences | 94.36M |